Pillstats
Rx only · Capsule · Oral

Pregabalin Capsules, Cv

Pregabalin

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US8 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN02BF02
RxCUI (US)187832
US makers1 labelers
Packages8
DEA / ScheduleCV

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.017$0.034$0.050$0.067Dec 2025Apr 2026Jul 2026
$0.052
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4218431.3K1.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
24
Rx · 2026 Q1
1.4K
Units dispensed
-98%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Cipla USA Inc.unknown8SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.